Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

Saftman 
07.07.22 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€199.88
26.06.22
-
26.06.23
5.34%
14.09.22

fenjal 
26.06.22 50%
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€112.82
11.06.22
-
11.06.23
2.07%
25.06.22

KongVestor 
11.06.22 50%
buy
Align Technology

Start price
Target price
Perf. (%)
€269.30
29.05.22
€380.00
29.05.23
-31.58%
27.10.22

RudolfL 
29.05.22 60%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€239.65
25.05.22
-
25.05.23
-5.90%
26.05.23

melinda 
25.05.22 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

Prof 
17.05.22 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
tbackenh 
25.04.22 50%
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€114.00
10.04.22
-
10.04.23
-32.91%
11.04.23

Systemtrader_mittelfrist_ 
10.04.22 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€267.40
10.04.22
-
10.04.23
-11.74%
11.04.23

Systemtrader_mittelfrist_ 
10.04.22 50%
buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€503.00
10.04.22
-
10.04.23
-13.34%
11.04.23

Systemtrader_mittelfrist_ 
10.04.22 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€329.95
02.04.22
€240.00
02.04.23
-34.40%
03.04.23

skatcup 
02.04.22 50%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€513.00
16.03.22
-
16.03.23
-2.32%
26.05.22

ElectricPlayer 
16.03.22 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€234.00
22.02.22
€270.00
22.02.23
-2.31%
23.02.23

gerihouse 
22.02.22 50%
buy
Align Technology

Start price
Target price
Perf. (%)
€450.50
01.02.22
€540.00
01.02.23
-37.41%
28.04.22

RudolfL 
01.02.22 60%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€246.90
30.01.22
€270.00
30.01.23
-9.98%
31.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
30.01.22 60%
buy
Stryker Corp.

Start price
Target price
Perf. (%)
€223.80
29.01.22
-
29.01.23
3.49%
29.01.23

Tekar 
29.01.22 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€408.10
26.01.22
€549.00
26.01.23
28.30%
23.09.22

gerihouse 
26.01.22 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€91.84
25.01.22
€95.00
25.01.23
-19.08%
26.01.23

melinda 
25.01.22 50%
sell
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
24.01.22 60%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
melinda 
24.01.22 50%
sell
Illumina Inc.

Start price
Target price
Perf. (%)
€364.50
11.01.22
-
11.01.23
-8.29%
21.01.22

Probably not worthwhile Investment
tinelchen 
11.01.22 0%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€318.90
08.01.22
-
08.01.23
18.00%
07.02.22

fenjal 
08.01.22 50%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€585.00
17.12.21
-
17.12.22
-11.15%
06.06.22

DropStone 
17.12.21 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€99.12
14.12.21
-
14.12.22
-25.68%
15.12.22

MBU 
14.12.21 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
13.12.21 60%